Huirong Pan

This inventor holds 7 USPTO granted patents and 5 EPO patents. Top assignees: Xiamen University, Xiamen Innovax Biotech Co., Ltd., Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.. Active years: 2014-2022.

USPTO Granted Patents = 7

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Xiamen, CN (2014 - 2017)
Fujian, CN (2016 - 2022)

Company Filing History:

Xiamen Innovax Biotech Co., Ltd.

patents

3 out of 15

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2014-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11339194 - Truncated rotavirus VP4 protein and application thereof (2022-05-24),

2. 10723767 - Truncated rotavirus VP4 protein and application thereof (2020-07-28),

3. 9745351 - Truncated L1 protein of human papillomavirus type 6 (2017-08-29),

4. 9499591 - Truncated L1 protein of human papillomavirus type 52 (2016-11-22),

5. 9364529 - Truncated L1 protein of human papillomavirus type 18 (2016-06-14),

6. 9249193 - Truncated L1 protein of human papillomavirus type 33 (2016-02-02),

7. 8748127 - Truncated L1 protein of human papillomavirus type 6 (2014-06-10),

Title: Huirong Pan: Innovator in Rotavirus Research

Introduction

Huirong Pan is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and pharmaceutical compositions for rotavirus infections. With a total of seven patents to his name, Pan's work is crucial in addressing health challenges associated with rotavirus.

Latest Patents

One of Huirong Pan's latest patents is focused on a truncated rotavirus VP4 protein and its applications. This invention encompasses a truncated rotavirus VP4 protein, a sequence encoding the same, and a method for preparing it. The pharmaceutical composition and vaccine that include this protein are designed to prevent, alleviate, or treat rotavirus infections and related diseases, such as rotavirus gastroenteritis and diarrhea. The invention also details the use of the protein in the manufacture of these pharmaceutical compositions or vaccines.

Career Highlights

Huirong Pan has worked with esteemed institutions, including Xiamen University and Xiamen Innovax Biotech Co., Ltd. His career reflects a strong commitment to advancing medical science and improving public health through innovative research.

Collaborations

Pan has collaborated with notable colleagues in his field, including Ningshao Xia and Jun Zhang. These partnerships have likely contributed to the success of his research and patent applications.

Conclusion

Huirong Pan's work in the development of rotavirus vaccines and treatments showcases his dedication to innovation in biotechnology. His contributions are vital for combating rotavirus infections and improving health outcomes globally.